Company intelligence / Profile preview

PharmaZell

Raubling, Bavaria, Germanyaxplora.com ↗

Ownership: Private
Employees: ~750
Development stage: Other

Overview

PharmaZell manufactures over 70 active pharmaceutical ingredients (APIs) with a focus on small molecules and complex formulations. The company supplies both generic and originator pharmaceutical sectors globally. It has a strong track record of growth and industry-leading margins. Its products are used in the treatment of various indications such as liver disease (notably ursodeoxycholic acid), respiratory disorders, and inflammatory conditions

Therapeutic areas: GastroenterologyPulmonologyImmunology
Modalities: Small moleculeAntibody-drug conjugate
Industry: Contract Manufacturing Organization

Partnerships

Not specifically disclosed; serves blue chip pharmaceutical companies globally as customers/partners

Beyond the preview

Go deeper on PharmaZell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaZell.

Explore the full profile